Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares rose 47.4% on Friday . The company traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares changed hands during trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Price Performance
The stock has a market capitalization of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The company’s 50-day simple moving average is C$0.08 and its 200-day simple moving average is C$0.06.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- Expert Stock Trading Psychology Tips
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- How to Effectively Use the MarketBeat Ratings Screener
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- When to Sell a Stock for Profit or Loss
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
